Cytotherapy (journal) explained

Cytotherapy
Cover:Cytotherapy (journal).jpg
Editor:Edwin Horwitz
Discipline:Cell biology, immunology, stem cells
Formernames:Cytokines, Cellular and Molecular Therapy; Cytokines and Molecular therapy
Abbreviation:Cytotherapy
Publisher:Elsevier on behalf of the International Society for Cell & Gene Therapy
Frequency:12/year
History:1999-present
Impact:5.414
Impact-Year:2020
Website:https://www.isct-cytotherapy.org/
Link1:https://www.isct-cytotherapy.org/current
Link1-Name:Online access
Link2:https://www.journals.elsevier.com/cytotherapy
Link2-Name:Online archive
Oclc:288963798
Lccn:00243205
Coden:CYTRF3
Issn:1465-3249
Eissn:1477-2566

Cytotherapy is a peer-reviewed medical journal covering the areas of cell and gene therapy. The journal was established in 1999 and is published by Elsevier on behalf of the International Society for Cell & Gene Therapy (ISCT). Cytotherapy is edited by Editor-in-Chief Edwin Horwitz, Managing Editor Kenneth W. Witwer, Commissioning Editor Patrick Hanley, and Assistant Editor Rachel Burga.

Aims and Scope

The Journal publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell and gene therapy. Cytotherapy publishes articles exploring the following topics:

Abstracting and indexing

This journal is abstracted and indexed in Science Citation Index Expanded, Current Contents/Clinical Medicine, Current Contents/ Life Sciences, BIOSIS Previews, and MEDLINE/PubMed. According to the Journal Citation Reports, the journal has a 2020 impact factor of 5.414.[1]

Notes and References

  1. Web site: Journal Citation Reports. . Clarivate Analytics. 2021-07-07.